Brainsway Ltd Total Liabilities

Latest as of June 2026: ILA42.79 Million ILA ≈ $114.71K USD

Brainsway Ltd total liabilities. Based on the latest financial reports, Brainsway Ltd (BWAY) has total liabilities worth ILA42.79 Million ILA (≈ $114.71K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check BWAY cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Brainsway Ltd (2012–2025)

Total liabilities of Brainsway Ltd from 2012 to 2025. This chart illustrates how Brainsway Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Brainsway Ltd to see how much of total assets are deployed in long-term investments.

Brainsway Ltd Competitors by Total Liabilities

The table below lists competitors of Brainsway Ltd ranked by their total liabilities.

Company Country Total Liabilities
Ningxia Xiaoming Agriculture & Animal Husbandry Co.Ltd
SHE:300967
China CN¥838.17 Million
Vishnu Chemicals Limited
NSE:VISHNU
India Rs10.13 Billion
Sports Gear Co. Ltd
TW:6768
Taiwan NT$8.58 Billion
Hung Ching Development & Construction Co Ltd
TW:2527
Taiwan NT$14.47 Billion
SAMPYO Cement Co. Ltd
KQ:038500
Korea ₩660.87 Billion
North American Financial 15
TO:FFN
Canada CA$588.15 Million
Issta Lines Ltd
TA:ISTA
Israel ILA2.29 Billion
Eurocharm Holdings Co Ltd
TW:5288
Taiwan NT$2.27 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Brainsway Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Brainsway Ltd asset portfolio.

Liquidity & Leverage Metrics

Brainsway Ltd Total Liabilities Ratios Explained

Brainsway Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 3.59 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.54 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.35 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Brainsway Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Brainsway Ltd (2012–2025)

The table below shows the annual total liabilities of Brainsway Ltd from 2012 to 2025.

Year Total Liabilities Change
2025-12-31 ILA34.67 Million
≈ $92.96K
+8.35%
2024-12-31 ILA32.00 Million
≈ $85.80K
+49.61%
2023-12-31 ILA21.39 Million
≈ $57.35K
+12.11%
2022-12-31 ILA19.08 Million
≈ $51.15K
+3.65%
2021-12-31 ILA18.41 Million
≈ $49.35K
+28.04%
2020-12-31 ILA14.38 Million
≈ $38.54K
-0.96%
2019-12-31 ILA14.52 Million
≈ $38.92K
-12.82%
2018-12-31 ILA16.65 Million
≈ $44.64K
+16.36%
2017-12-31 ILA14.31 Million
≈ $38.36K
+47.87%
2016-12-31 ILA9.68 Million
≈ $25.94K
+3.52%
2015-12-31 ILA9.35 Million
≈ $25.06K
-8.30%
2014-12-31 ILA10.19 Million
≈ $27.33K
+219.03%
2013-12-31 ILA3.20 Million
≈ $8.57K
+90.21%
2012-12-31 ILA1.68 Million
≈ $4.50K
--

About Brainsway Ltd

TA:BWAY Israel Medical Devices
Market Cap
$394.54 Million
ILA147.16 Billion ILA
Market Cap Rank
#13128 Global
#140 in Israel
Share Price
ILA3656.00
Change (1 day)
+3.72%
52-Week Range
ILA2423.00 - ILA5074.00
All Time High
ILA5074.00
About

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more